La titularidad de los derechos patrimoniales de esta obra pertenece a las instituciones editoras. Su uso se rige por una licencia Creative Commons BY 4.0 Internacional, https://creativecommons.org/licenses/by/4.0/legalcode.es, para un uso diferente consultar al responsable jurídico del repositorio por medio del correo electrónico vetmexicooa@fmvz.unam.mx.
Ver términos de la licencia
Facultad de Medicina Veterinaria y Zootecnia, UNAM
Revista
Repositorio
Contacto
Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx
Gutiérrez, Lilia, et al. (2023). A pharmacological perspective on the use of Benzylpenicillin-G in the production of veterinary medicine in Latin America. Veterinaria México OA; Vol. 10, 2023. Recuperado de https://repositorio.unam.mx/contenidos/4149033
Autor(es)
Gutiérrez, Lilia; Sumano, Héctor; Ocampo, Luis; Nieto, Agustín; Aquino, Itzcoatl
Tipo
Artículo de Investigación
Área del conocimiento
Biotecnología y Ciencias Agropecuarias
Título
A pharmacological perspective on the use of Benzylpenicillin-G in the production of veterinary medicine in Latin America
Fecha
2023-03-06
Resumen
Benzylpenicillin-G (BP-G) is one of human and veterinary medicine’s most widely used antibacterial drugs. It represents a large market for the Pharmaceutical Industry, and various combinations with frail pharmacological support have been made available to veterinarians. The crystalline sodium and potassium salts of BP-G and the benzathine salt of BP-G have been incorporated into many existing preparations, arguing that higher and more prolonged concentrations are obtained. However, there are not evidence published. Notwithstanding the above, these preparations are presented as sustained-release ones and capable of achieving therapeutic concentrations. There are no pharmacokinetic bases for such combinations of BP-G derivatives. It is unlikely that such combinations provide better serum profiles than those offered by an adequate dose of only procaine BP-G. The incorporation of the BP-G benzathine is prohibited in many countries. In Latin America, such combinations limit the amount of procaine BP-G that should be injected, ideally ≥ 20 000 IU/kg of body weight every 12-24 h. Within the framework of the rational use of antimicrobial drugs in veterinary medicine advanced by the World Health Organization (WHO) and based on pharmacological considerations, it is proposed that combinations of BP-G derivatives be restricted, allowing only BP-G procaine preparations. Also, formulations of BP-G incorporating other active principles should offer solid pharmacological support. To date, combined preparations of BP-G have shown no formal pharmacological support. Based on the information presented in this review, it is feasible to conclude that the only BP-G derivative that should be available for veterinary medicine is procaine BP-G.
Tema
Bencylpenicillin-g; Pharmacokinetics/pharmacodynamics; Antibacterial Resistance; Commercial Preparations; Veterinary Medicine
Idioma
eng
ISSN
ISSN electrónico: 2448-6760
